EnClear Therapies

EnClear Therapies is a biotechnology company headquartered in Cambridge, Massachusetts, USA. The company has developed a device to treat neurological disorders. Anthony R. DePasqua, co-founder and CEO of EnClear Therapies, led the development of this device, which can filter out toxic proteins that accumulate in the brains and spinal cords of patients with neurodegenerative diseases, and provide closed-loop delivery and monitoring of cerebrospinal fluid (CSF).